• Follow us:



Biosortia has a fully proven peer-reviewed microbiome mining technology (IP & supported by ARPA-E, DARPA, USAFRL), solid traction, strong team, massive market opportunity, & game-changing unique position with first-mover advantage.

Biosortia is able to obtain the hidden secrets of the cell to cell signaling and modulation that no other technology or team has ever achieved. This will bring the actual hidden chemistry of life into the researcher’s hands for new products in therapeutics, longevity, agriculture, cosmetics, and more.

Is there any interest in learning more about how far our technology has progressed?

Please contact us at the email below for more information and conversation with our Ownership Team.

Send a message

Interested in learning more about investing in Biosortia or current investors requesting access to secure site.

Please complete the form below or email inquiries@biosortia.com


    To protect prospective investors, Rule 241 communications must state that (i) the issuer is considering an exempt offering but has not determined the specific exemption, (ii) no money or other consideration is being solicited, and none will be accepted, (iii) no offer to buy the securities can be accepted and no part of the purchase price can be received until the issuer determines what the exemption will be and any applicable filing, disclosure, and qualification requirements are met, and (iv) a prospective investor’s indication of interest involves no obligation or commitment of any kind. Such communications may include the means by which a person may indicate their interest, and may require the person’s name, address, telephone number, and/or email address to be completed in the form located on this page.


    Pin It on Pinterest